Paxys, Inc. (PSE:PAX)

Regulus Therapeutics Ratios and Metrics

Market cap in millions PHP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,007	1,365	923	1,469	1,686	1,887
Market Cap Growth	150.00%	47.83%	-37.16%	-12.86%	-10.64%	-12.64%
Enterprise Value	-2,255	-2,776	-3,065	-2,555	-1,990	-1,708
Last Close Price	2.50	1.70	1.15	1.83	2.10	2.35
PE Ratio	15.44	10.31	8.34	47.29	-	-
PS Ratio	704.31	193.94	55.42	50.59	37.74	34.53
PB Ratio	0.46	0.31	0.23	0.37	0.45	0.52
P/TBV Ratio	0.46	0.31	0.23	0.37	0.45	0.52
P/FCF Ratio	15.47	10.12	10.64	17.89	16.36	19.65
P/OCF Ratio	15.44	10.11	10.64	17.78	16.24	19.49
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.01
Debt / FCF Ratio	0.07	0.08	0.27	0.55	0.49	0.26
Asset Turnover	0.00	0.00	0.00	0.01	0.01	0.01
Quick Ratio	118.37	134.84	101.35	80.18	92.44	108.59
Current Ratio	122.60	136.83	102.70	81.26	93.13	109.39
Return on Equity (ROE)	2.96%	3.13%	2.74%	0.80%	-0.36%	-0.70%
Return on Assets (ROA)	-1.24%	-1.25%	-1.20%	-1.07%	-1.02%	-1.23%
Return on Capital (ROIC)	-1.25%	-1.26%	-1.21%	-1.08%	-1.03%	-1.24%
Earnings Yield	6.29%	9.70%	11.99%	2.11%	-0.80%	-1.37%
FCF Yield	6.46%	9.88%	9.40%	5.59%	6.11%	5.09%

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.